More on Cardinal Health (CAH) FQ1: net profit +15% to $271M. Pharmaceutical revenue -4% to...

|About: Cardinal Health Inc. (CAH)|By:, SA News Editor

More on Cardinal Health (CAH) FQ1: net profit +15% to $271M. Pharmaceutical revenue -4% to $23.5B but profit +10%, due to increased sales of generic drugs, which are cheaper but can provide higher margins. Medical business revenue +1% to $2.39B. Expects FY EPS of $3.35-$3.50 vs consensus of $3.43.